KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 63 filers reported holding KINNATE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188 | -48.8% | 134 | +10.7% | 0.00% | – |
| Q2 2023 | $367 | -98.8% | 121 | -97.6% | 0.00% | – |
| Q1 2023 | $31,894 | +1631.5% | 5,103 | +1589.7% | 0.00% | – |
| Q4 2022 | $1,842 | -54.0% | 302 | +6.0% | 0.00% | – |
| Q2 2022 | $4,000 | -71.4% | 285 | -76.5% | 0.00% | – |
| Q1 2022 | $14,000 | -93.4% | 1,211 | -89.8% | 0.00% | – |
| Q4 2021 | $211,000 | +21000.0% | 11,926 | +25826.1% | 0.00% | – |
| Q3 2021 | $1,000 | -66.7% | 46 | -66.9% | 0.00% | – |
| Q2 2021 | $3,000 | -97.7% | 139 | -96.7% | 0.00% | – |
| Q1 2021 | $131,000 | – | 4,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $225,156,000 | 30.44% |
| Vida Ventures Advisors, LLC | 2,747,433 | $63,960,000 | 16.04% |
| Foresite Capital Management V, LLC | 875,001 | $20,370,000 | 8.01% |
| VR Adviser, LLC | 1,473,014 | $34,292,000 | 4.16% |
| Logos Global Management LP | 1,329,602 | $30,953,000 | 2.60% |
| RA Capital Management | 3,593,052 | $83,646,000 | 1.34% |
| Orbimed Advisors | 3,847,929 | $89,580,000 | 0.91% |
| Boxer Capital, LLC | 1,065,939 | $24,815,000 | 0.88% |
| HARVARD MANAGEMENT CO INC | 498,001 | $11,593,000 | 0.67% |
| HighVista Strategies LLC | 33,391 | $777,000 | 0.55% |